The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 29, 2021
Filed:
Mar. 15, 2019
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
Kristof Chwalisz, Mundelein, IL (US);
Laura A. Williams, Gurnee, IL (US);
Rita I. Jain, Evanston, IL (US);
Janine D. North, Chicago, IL (US);
Juki Wing-Keung Ng, Highland Park, IL (US);
Assignee:
ABBVIE INC., North Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/513 (2006.01); A61K 45/06 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61P 15/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 45/06 (2013.01); A61P 15/00 (2018.01);
Abstract
The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.